Anika Therapeutics (NASDAQ:ANIK) Price Target Cut to $19.00 by Analysts at Barrington Research
Anika Therapeutics (NASDAQ:ANIK – Free Report) had its target price reduced by Barrington Research from $20.00 to $19.00 in a report released on Monday,Benzinga reports. Barrington Research currently has an outperform rating on the biotechnology company’s stock. Other analysts also recently issued reports about the stock. B. Riley assumed coverage on shares of Anika Therapeutics […]
